Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series

by Rachel A. Brown, Fatima Barbar-Smiley, Cagri Yildirim-Toruner, Monica I. Ardura, Stacy P. Ardoin, Shoghik Akoghlanian
Published 2021-06-01

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)

by Stephanie L. Savelli, Stephanie L. Savelli, Stephanie L. Savelli, Robert A. S. Roubey, Kathryn J. Kitzmiller, Kathryn J. Kitzmiller, Danlei Zhou, Danlei Zhou, Danlei Zhou, Haikady N. Nagaraja, Evan Mulvihill, Evan Mulvihill, Fatima Barbar-Smiley, Fatima Barbar-Smiley, Stacy P. Ardoin, Stacy P. Ardoin, Yee Ling Wu, Yee Ling Wu, Yee Ling Wu, Chack-Yung Yu, Chack-Yung Yu, Chack-Yung Yu
Published 2019-05-01

Exploring Pediatric Tele-Rheumatology Practices During COVID-19: A Survey of the PRCOIN Network

by Y. Ingrid Goh, Y. Ingrid Goh, Danielle R. Bullock, Janalee Taylor, Rajdeep Pooni, Tzielan C. Lee, Sheetal S. Vora, Cagri Yildirim-Toruner, Cagri Yildirim-Toruner, Esi M. Morgan, Nancy Pan, Julia G. Harris, Andrew Warmin, Kendra Wiegand, Jon M. Burnham, Fatima Barbar-Smiley
Published 2021-03-01